Well, I don't know that over riding a patent would necessarily mean that compensation would not be paid to GSK and Biota. Can't it mean merely that a government directs the manufacture of the drug in an emergency, ignoring manufacturing rights that are exclusive to GSK and Biota.
Anyone know what has happened in precedents?
tjw dank summit document, page-3
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)